Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...

Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).   Citius Announces Pre-IND Submission to FDA Under the Coronavirus...

True Nature | Mitesco (MITI) Raising $15 Million.

LIVE CHART Mitesco, Inc. Announces up to $15 Million Unit Preferred Capital...
Immunomedics IMMU, Biotech Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value.

Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If...
American BriVision

American BriVision (ABVC) Improves Working Capital and Reduce Debt.

American BriVision Announces Two Financial Transactions to Improve Working Capital and Reduce Debt FREMONT, CA, April 13, 2020...
America BriVision, Biotech Stock Review

Adding American BriVision (ABVC) $2.00 to Watch List.

New client and an incubator, studying now. Thinly, thinly traded. We like what we've read so far about their vitreous substitute (eyeball...
Biotech Stock Review, Novellus, Citius

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.

Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.
OMNIQ

OMNIQ (OMQS) Corp. Acquires Eyepax Parking Assets.

OMNIQ Corp. Acquires Eyepax USA's Intellectual Property and Technology to Establish Leadership in Multibillion Dollar Automated Parking Solutions Market
Biotech Stock Review

Regular Old Flu, Kills 290,000 to 650,000 a Year.

Be Careful of the Regular Flu. Not in any way to downplay Corona's deadly path - but even...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...